DBC1 promotes metastatic castration-resistant prostate cancer by enhancing the stability and activity of HSF1 [ChIP-seq]
ChIP-seq / ATAC-seq (genome binding and open chromatin) · human · 37 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Homo sapiens (human)
- Topic
- Prostate cancerThis series is part of our curated briefing on it.
- Samples
- 37 samples: 37 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- HSF1-DBC1 axis drives prostate cancer progression by activating a metastatic transcriptional programExperimental & molecular medicine · 2025
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE276302_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1156585 and SRA study SRP530416. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 37 sample titles: 37 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8496166 HSF1_NHS_22RV1
- GSM8496167 HSF1_NHS_22RV1_H1KO
- GSM8496168 HSF1_NHS_22RV1_D1KO
- GSM8496169 HSF1_HS_22RV1
- GSM8496170 HSF1_HS_22RV1_H1KO
- GSM8496171 HSF1_HS_22RV1_D1KO
- GSM8496172 Input_HSF1_NHS_22RV1
- GSM8496173 Input_HSF1_NHS_22RV1_H1KO
- GSM8496174 Input_HSF1_NHS_22RV1_D1KO
- GSM8496175 Input_HSF1_HS_22RV1
- GSM8496176 Input_HSF1_HS_22RV1_H1KO
- GSM8496177 Input_HSF1_HS_22RV1_D1KO
- GSM8496178 K27ac_NHS_22RV1
- GSM8496179 K27ac_NHS_22RV1_H1KO
- GSM8496180 K27ac_NHS_22RV1_D1KO
- GSM8496181 K27ac_HS_22RV1
- GSM8496182 K27ac_HS_22RV1_H1KO
- GSM8496183 K27ac_HS_22RV1_D1KO
- GSM8496184 Input_K27ac_NHS_22RV1
- GSM8496185 Input_K27ac_NHS_22RV1_H1KO
- GSM8496186 Input_K27ac_NHS_22RV1_D1KO
- GSM8496187 Input_K27ac_HS_22RV1
- GSM8496188 Input_K27ac_HS_22RV1_H1KO
- GSM8496189 Input_K27ac_HS_22RV1_D1KO
- GSM8496190 HSF1_NHS_SM1
- GSM8496191 HSF1_NHS_SM1_H1KO
- GSM8496192 HSF1_NHS_SM1_D1KO
- GSM8496193 K27ac_NHS_SM1
- GSM8496194 K27ac_NHS_SM1_H1KO
- GSM8496195 K27ac_NHS_SM1_D1KO
- GSM8496196 Input_NHS_SM1
- GSM8496197 Input_NHS_SM1_H1KO
- GSM8496198 Input_NHS_SM1_D1KO
- GSM8496199 DBC1_NHS_SM1
- GSM8496200 DBC1_NHS_SM1_D1KO
- GSM8496201 Input_DBC1_NHS_SM1
- GSM8496202 Input_DBC1_NHS_SM1_D1KO
- GSE115501 RNA sequencing on circulating tumor cells from prostate cancer patients 136 samples same disease briefing · shares prostate
- GSE222467 The RNA binding proteins LARP4A and LARP4B promote tumour growth and metastasis in prostate cancer and osteosarcoma 12 samples same disease briefing · shares prostate
- GSE300947 A novel six-biomarker panel identified from male breast cancer-associated fibroblasts demonstrates prognostic power for prostate tumors 6 samples same disease briefing · shares prostate
- GSE120181 Human prostate cancer cell line, 22Rv1: Control vs. luteolin treatment 2 samples same disease briefing · shares prostate
- GSE71008 Plasma extracellular RNA profiles in healthy and cancer patients 192 samples same disease briefing
- GSE242541 ONECUT2 is a druggable driver of luminal to basal breast cancer plasticity 12 samples same disease briefing
- GSE276301 DBC1 promotes metastatic castration-resistant prostate cancer by enhancing the stability and activity of HSF1 [RNA-seq] 10 samples shares dbc1, hsf1, castration-resistant, metastatic, enhancing, stability, promotes, prostate
- GSE229394 Molecular and immune profiles linked to androgen response categories in metastatic castration-resistant prostate cancers (mCRPC) 56 samples shares castration-resistant, metastatic, prostate
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.